Versant Ventures VI GP-GP, LLC
- SEC CIK
- 0001777652
In the past year, 1 open-market sale filing worth $10.4M and no purchases.
Current role at each company
- LENZ LENZ Therapeutics, Inc.10% Owneras of Oct 2, 2025
- LVTX LAVA Therapeutics NV10% Owneras of Sep 23, 2025
- GLUE Monte Rosa Therapeutics, Inc.10% Owneras of Oct 30, 2024
- TPST Tempest Therapeutics, Inc.10% Owneras of Aug 12, 2024
- CTNM Contineum Therapeutics, Inc.10% Owneras of Apr 11, 2024
Show 3 more companies
- OYST Oyster Point Pharma, Inc.10% Owneras of Jan 4, 2023
- IPSC Century Therapeutics, Inc.10% Owneras of Aug 11, 2022
- RPTX Repare Therapeutics Inc.10% Owneras of Jun 7, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $10.4M
- 1 filing
- Net
- −$10.4M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Versant Ventures VI GP-GP, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LENZ LENZ Therapeutics, Inc.
10% Owner14 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 (view filing)4:40 PM ET | Sep 30 | 2 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −132.9K | $46.01 | −$6.12M | −11.2%1.05M after | 3 lots |
| Oct 2, 2025 (view filing)4:40 PM ET | Sep 30 | 2 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −92.0K | $46.01 | −$4.23M | −10.7%764.1K after | 3 lots |
| Sep 22, 2025 (view filing)4:23 PM ET | Sep 18 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −90.7K | $42.23 | −$3.83M | −7.1%1.18M after | 3 lots |
| Sep 22, 2025 (view filing)4:23 PM ET | Sep 18 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −44.6K | $42.23 | −$1.89M | −5.0%856.2K after | 3 lots |
| Aug 26, 2025 (view filing)7:59 PM ET | Aug 22-26 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −126.0K | $39.47 | −$4.97M | −9.0%1.27M after | 6 lots |
| Aug 26, 2025 (view filing)7:59 PM ET | Aug 22-26 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −62.1K | $39.47 | −$2.45M | −6.4%900.8K after | 6 lots |
| Aug 19, 2025 (view filing)4:51 PM ET | Aug 15-18 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −175.7K | $39.34 | −$6.91M | −11.1%1.40M after | 2 lots |
| Aug 19, 2025 (view filing)4:51 PM ET | Aug 15-18 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −85.0K | $39.33 | −$3.34M | −8.1%962.9K after | 2 lots |
| Jul 14, 2025 (view filing)4:50 PM ET | Jul 10 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −191.4K | $34.00 | −$6.51M | −10.8%1.58M after | |
| Jul 1, 2025 (view filing)6:16 PM ET | Jun 27 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −200.0K | $30.47 | −$6.09M | −10.2%1.77M after |
LVTX LAVA Therapeutics NV
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2025 (view filing)4:33 PM ET | Sep 19 | 4 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −2.37M | $1.40 | −$3.32M | −100.0%0 after | |
| Sep 23, 2025 (view filing)4:33 PM ET | Sep 19 | 4 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −532.9K | $1.40 | −$746.8K | −100.0%0 after | |
| Sep 18, 2025 (view filing)6:49 PM ET | Sep 16-18 | 2 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −1.04M | $1.49 | −$1.54M | −30.4%2.37M after | 3 lots |
| Sep 18, 2025 (view filing)6:49 PM ET | Sep 16-18 | 2 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −647.8K | $1.49 | −$962.3K | −54.9%532.9K after | 3 lots |
GLUE Monte Rosa Therapeutics, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 30, 2024 (view filing)4:35 PM ET | Oct 28-29 | 2 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −157.9K | $9.44 | −$1.49M | −9.1%1.57M after | 3 lots |
| Sep 24, 2024 (view filing)4:40 PM ET | Sep 20 | 4 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −1.13M | $6.53 | −$7.40M | −18.2%5.10M after | |
| Sep 13, 2024 (view filing)6:44 PM ET | Sep 11-13 | 2 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −567.2K | $6.00 | −$3.40M | −8.3%6.23M after | 3 lots |
TPST Tempest Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 (view filing)8:33 PM ET | Aug 8-12 | 4 days | Versant Ventures IV, LLC and 8 others10% Owner | SSale | −788.0K | $1.23 | −$967.0K | −79.0%209.9K after | 2 lots |
IPSC Century Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2022 (view filing)4:55 PM ET | Aug 9 | 2 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −550.0K | $13.03 | −$7.17M | −4.4%11.8M after |
RPTX Repare Therapeutics Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 (view filing)4:36 PM ET | Jun 3 | 4 days | Versant Affiliates Fund V, L.P. and 9 others10% Owner | SSale | −750.0K | $12.25 | −$9.19M | −87.1%111.5K after | 5 lots |
OYST Oyster Point Pharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2021 (view filing)4:38 PM ET | Oct 18 | 2 days | Versant Ventures IV, LLC and 8 others10% Owner | SSale | −550.0K | $14.84 | −$8.16M | −99.1%4.99K after | 4 lots |